Fenfluramine and dexfenfluramine were two popular diet drugs prior to their 1997 recall. Marketed as Pondimin and Redux respectively, the drugs were often used in combination with another drug, phentermine. In all, Fen-Phen, was used by more than 6 million Americans for weight loss.
Unfortunately, in 1997 Fen-Phen was linked to two life-threatening conditions - heart valve disease and primary pulmonary hypertension (PPH). Heart valve disease causes damage to the valves in the heart that control blood flow to the body. The condition causes the valves to regurgitate blood, which strains the heart. Over 100 cases of heart valve disease had been reported to the Food and Drug Administration (FDA) at the time of Fen-Phen's removal from the market. It is now estimated that approximately 30% of former Fen-Phen patients suffer from some heart valve abnormalities. PPH is a very serious condition in which the lungs' blood vessels narrow. This constricts the amount of blood that can pass through these vessels and often results in high blood pressure. Heart and lung failure can eventually occur. A transplant may be necessary, and PPH can be fatal.
If you have taken Fen-Phen and have not yet seen a physician for evaluation, we recommend that you do so as soon as possible. Intervention with medication, valve surgery, or transplant may be necessary. Please also remember that you have legal rights. If you, or a loved one, have been injured by Fen-Phen, please contact us today!